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New Information During Challenging Times*Olaf Wendler, MD, PHD, Max Baghai, PHDS urgical site infections (SSIs) are one of the mostchallenging complications of surgery, for pa-tients and surgeons alike. For that reason, it
is interesting to note that in this recent experience, re-
ported by Gelijns et al. (1) in this issue of the Journal,
of more than 5,000 patients who underwent various
cardiac surgeries including cardiac transplantation,
SSIs played only a minor role (1). The majority ofSEE PAGE 372infections observed were pneumonia, bloodstream in-
fections, and C. difﬁcile colitis, which accounted for
79% of all major post-operative infections. Although
we should not underestimate the importance of SSIs,
the continued improvements in care delivery in
recent years have had a signiﬁcant impact on patients
undergoing cardiac surgery.
Historically, institutions and surgeons assessed
and reported only on their individual outcomes to
improve their practice, as well as to reassure them-
selves and their patients about their quality of care.
Over the last 20 years, cardiothoracic societies have
been on the forefront to collect national data on car-
diac surgery and its outcomes. Now, these data are
available in the public domain. For that purpose,
national societies such as the Society of Thoracic
Surgeons and the Society for Cardiothoracic Surgery
have developed databases in which surgical outcomes
of their members are collected in standardized
fashion, with the aim of covering the national activity
for their specialty. These data have been used to* Editorials published in the Journal of the American College of Cardiology
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disclose.create benchmarks and to identify areas of care,
which could beneﬁt from further improvements.
In numerous countries, including the United States
and United Kingdom, we are entering an interesting
next phase in that, outcomes after cardiac surgery—
which include immediate and mid-term follow-up—
will be directly correlated to reimbursement. In the
United Kingdom, this is known as “Payment by
Results” (PbR). In the United States, the Centers of
Medicare and Medicaid Services (CMS) decided to
withhold reimbursement for care relating to post-
operative complications including SSIs, mediastinitis
after coronary artery bypass grafting, urinary tract
infections, and intravenous catheter-associated in-
fections. For this reason alone, it is vital to know
more about the incidence and associated risk factors
for certain complications in a normal cohort of pa-
tients undergoing cardiac surgery today. The ﬁndings
by Gelijns et al. (1) will hopefully inﬂuence healthcare
providers when building new policies. Previous
reports generally focused more on speciﬁc types of
surgical procedures and reported on in-hospital or
30-day results. Gelijns et al. (1) provide vital infor-
mation on a diverse cohort of patients undergoing
cardiac surgery and include not only early but also
mid-term outcomes up to 65 days after surgery. This
astute approach has led to the ﬁnding that 45% of all
post-operative infections occur after discharge. While
this is important for the patients’ recovery, it also has
signiﬁcant economic implications as it leads to read-
missions and delayed rehabilitation of patients.
When it comes to reimbursement and penalties of
complications, it is of tremendous importance to
distinguish between post-operative complications as
a result of individual patient or surgical characteris-
tics and those due to quality of care. In this in-
vestigation, the authors identify baseline patient
demographics such as chronic lung disease, heart
failure, and elevated creatinine as predictors of
post-operative infections, while previously known
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383characteristics such as obesity, diabetes, and urgent
surgery did not play a role. Given that surgeons and
institutions cannot inﬂuence the risk proﬁle of indi-
vidual patients, healthcare providers should not
scrutinize treatment of these individuals by the same
ﬁnancial penalties introduced for patients without a
high-risk proﬁle for cardiac surgery.
Alternatively, healthcare providers can expect a
high standard of care, which is known to reduce
complications such as infections. The authors provide
important information on which medical practices
reduce infectious complications after cardiac surgery.
Perioperative prophylaxis using second-generation
cephalosporins proved to be of prophylactic value in
North America, but it should not be given for more
than 48 h after surgery. In addition, post-operative
hyperglycemia is identiﬁed as a signiﬁcant risk fac-
tor for infections. While it is well known that post-
operative normoglycemia improves patient outcome
(2), it raises the question why diabetes mellitus was
not a risk factor. It would be interesting to see if the
subgroup of diabetic mellitus patients who are insulin
dependent were found to be at higher risk for post-
operative infections. However, these ﬁndings may
support the CMS decision to introduce performance
measures such as choice and timing of antibiotics,
control of early post-operative blood glucose level,
and appropriate surgical site hair removal into their
reimbursement scheme.
When it comes to quality of care and surgery
itself, it is important to notice that “prolonged sur-
gery” in this report predicted infective complica-
tions, which aligns with previous studies. While
surgery can be unavoidably prolonged due to the
nature of certain surgical procedures (e.g., combined
complex coronary artery bypass grafting and heart
valve surgeries or thoracic aortic surgery), it also can
be an indicator of inferior surgical care in cases of
routine operations taking longer than expected. If
both these patient groups would be affected by
reimbursement penalties in the same way, it would
not be difﬁcult to imagine that patients who face
high perioperative risks because of their individual
characteristics or speciﬁc planned procedure, would
be at risk of not ﬁnding surgeons or institutions
prepared to take additional medical and economical
risks in the future. This scenario needs to be avoi-
ded, as it is well known that these patients often
have an even greater prognostic and symptomatic
beneﬁt from their surgery compared with patients
who have lower risk proﬁles. Therefore, the question
needs to be raised if these individuals and surgical
procedures should be taken off the list of treatments
affected by PbR?What is not documented in this paper are data on
how patients were screened for their infectious status
prior to admission. This is of even more importance as
the number of patients colonized with multiresistant
microorganisms, such as MRSA, is steadily increasing.
Therefore, pre-admission nasal and skin swabs
should be a routine, standardized screening protocol
for urgent or in-hospital patients. In this respect, it
may be interesting that nasal decontamination in this
investigation did not have a positive effect on the
incidence of infections, in contrast to a previously
published randomized trial (3). It does, however, raise
the question of whether this is only due to the fact
that most patients treated did not present with
pathological nasal contamination and these results
may have been different if treatment was selected
only for patients with pathological colonization.
There are 2 ﬁndings in this investigation, which
should further encourage us to review current stan-
dards of care. While the duration of mechanical
ventilation is well known to have a negative effect on
post-operative infections, blood transfusions have
been more recently identiﬁed as independent pre-
dictors of negative outcome after surgery (4). Given
that an intubation time of 24 to 48 h and mechanical
ventilation of more than 48 h increases the risk of
infections, it is of even more importance to have
treatment protocols and close collaboration between
surgeons and anesthesiologists in place, which enable
early extubation post-surgery. In our own institution,
post-operative ventilation time for all comers of car-
diac surgery has been continuously reduced over
recent years to a mean of 12 h, with 85% of patients
extubated <6 h after cardiac surgery. As a result, the
incidence of respiratory complications has been
reduced, and <10% of all patients need to be admitted
to intensive care facilities at any time after cardiac
surgery. Reduction in the length of hospital stay and
overall treatment costs are a positive side effect of
this strategy.
In recent years, a number of investigations dem-
onstrated that blood transfusions are an independent
risk factor for inferior outcomes after surgery.
Therefore, it was not surprising to read that this is also
true for patients after cardiac operations. Unfortu-
nately, hemoglobin thresholds for blood transfusions
are not reported in this study and therefore we believe
that they vary between the institutions or surgeons
involved. In general, lower hemoglobin thresholds
than previously advised should be used, as was
recently recommended (5). In our institution, a he-
moglobin of 8 g/l is currently accepted for cardiore-
spiratory stable patients after cardiac surgery. While a
number of blood conservation strategies, such as
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384autologous transfusion and cell saving, have been well
established, there is generally a less cohesive opinion
among surgeons on how patients with preoperative
anemia should be treated before surgery. This recently
published data raise the question that if patients with
preoperative anemia should undergo preoperative
treatment using oral or even intravenous iron, which
is suggested for other types of surgery?
In summary, we would like to congratulate the
authors for this excellent investigation on a real-
world cohort of patients undergoing cardiac surgery.These data come at the right time as PbR is more
frequently discussed, highlighting the challenge of
ﬁtting high-risk patients into these new reimburse-
ment arrangements, without ﬁrst addressing their
individual risk proﬁle or overlooking their medical
needs.
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